Related News

No related news articles were found.

hpgc renmintongtai pharmac-a (600829) Related Businessweek News

No Related Businessweek News Found

hpgc renmintongtai pharmac-a (600829) Details

HPGC Renmintongtai Pharmaceutical Corporation produces and sells OTC products and prescription drugs in China and internationally. It primarily produces and manages Chinese and western medicine in various dosage forms, including small volume injections, oral liquids, oral solutions, mixtures, aerosol, pills, dropping pills, raw medicines, sterile raw medicines, powder injections, little capacity injections, tablets, capsules, lotions, granules, spraying agents, freeze-dried injections, lyophilization injections, creams and ointments, eye drops, and other products. The company is also involved in the wholesale of chemical preparations, Chinese patent medicine, antibiotics, biochemical medicine, chemical raw medicine, narcotics, and psychotropic drugs; and health foods. In addition, it imports and exports goods and technologies, as well as is involved in other businesses. The company was formerly known as Harbin Pharm Group Sanjing Pharmaceutical Shareholding Co., Ltd. and changed its name to HPGC Renmintongtai Pharmaceutical Corporation in April 2015. HPGC Renmintongtai Pharmaceutical Corporation was founded in 1950 and is based in Harbin, China.

hpgc renmintongtai pharmac-a (600829) Key Developments

HPGC Renmintongtai Pharmaceutical Corporation, Board Meeting, May 29, 2015. Agenda: To discuss and approve the proposal of adjustment of prediction of daily connected transactions in 2015; to discuss and approve the proposal of applying for entrust loan to Harbin Pharmaceutical Group Co., Ltd.; and to discuss and approve the proposal of amending 'rules of order for shareholders' meeting' and other corporate governance systems.

HPGC Renmintongtai Pharmaceutical Corporation, Special/Extraordinary Shareholders Meeting, Jun 26, 2015., at 10:00 China Standard Time. Agenda: To discuss the proposal of adjustment to prediction of daily connected transactions in 2015; to discuss the proposal of applying for entrusted loan to Harbin Pharmaceutical Group Co., Ltd.; and to discuss the proposal of amending rules of order for shareholders meeting and other corporate governance systems.

Sanjing Pharmaceutical Announces Earnings Results for the First Quarter of 2015

Apr 22 15

Sanjing Pharmaceutical announced earnings results for the first quarter of 2015. For the quarter, the company recorded operating income of CNY 2.705 billion, growing 7.91% year on year. Net profits attributable to shareholders reached CNY 63.038 million, growing 25.29% year on year.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.